GLOBAL GENOMICS CAPITAL

Global Genomics Capital is a privately held genomics company.

#SimilarOrganizations #More

GLOBAL GENOMICS CAPITAL

Industry:
Biotechnology Pharmaceutical

Address:
Los Angeles, California, United States

Country:
United States

Status:
Active


Similar Organizations

stella-therapeutics-logo

Stella Therapeutics

Stella Therapeutics, a privately held drug discovery company.

trimgen-logo

TrimGen

TrimGen is a privately held diagnostic company.

More informations about "Global Genomics Capital"

Global Genomics Capital - Crunchbase

Global Genomics Capital is a privately held genomics company.See details»

Global Genomic Medicine Collaborative (GGMC)

The Global Genomic Medicine Collaborative (GGMC) is a global organization headquartered in North Carolina, USA, with a mission to advance genomic medicine integration efforts โ€ฆSee details»

CytRx - Funding, Financials, Valuation & Investors - Crunchbase

Sep 22, 2008 Which types of acquisition does this organization make most frequently? Show . Acquiree Name ... acquired by CytRx . Biorex Research and Development . Oct 4, 2004: $3M: โ€ฆSee details»

Global Genomic Medicine Collaborative โ€“ Organizational Growth โ€ฆ

Feb 24, 2022 The Consortium, along with the International Hundred K+ Cohorts Consortium (IHCC) will become a part of the parent organization, the Global Genomic Medicine โ€ฆSee details»

Interview with Dr. Szilard Voros, Ceo and Co-Founder โ€ฆ

Dr. Szilard Voros, CEO and co-founder of Global Genomics Group (G3), is currently heading the international GLOBAL study, which will enroll up to 10,000 patients with coronary artery disease. The coronary atherosclerotic disease of โ€ฆSee details»

Leadership - Global Genomic Medicine Collaborative

About GGMC Leadership Team Grant Wood CEO BOARD OF DIRECTORS Professor Vajira H. W. Dissanayake, MBBS, PhD, FNASSL Chair & President Governance Committee MemberDevelopment Committee Member Alan โ€ฆSee details»

Genome Capital

Genome Capital believes that now is the right time to invest in: Healthcare costs continue to grow at a rapid pace. Genome Capital believes that now is the right time to invest in: ... Principal of 3,000-member global tech founders' โ€ฆSee details»

Increasing nursing capacity in genomics: Overview of existing โ€ฆ

The Global Genomics Nursing Alliance (G2NA) was established in January 2017 to accelerate the integration of genomics into everyday practice. ... describe the resources necessary to build โ€ฆSee details»

CytRx acquires Global Genomics Capital - 2002-02-18 - Crunchbase

Feb 18, 2002 Acquired Organization: Global Genomics Capital Global Genomics Capital is a privately held genomics company. Acquiring Organization: CytRx CytRx is a โ€ฆSee details»

Genomic Research and Development Centre: Investment Trends: โ€ฆ

The advent of genomic research has ushered in a new era of biotechnology, fundamentally altering the landscape of medical science and the global economy. This transformative field โ€ฆSee details»

Global Genomics Group LLC - BioCentury Company Profiles - BCIQ

Global Genomics Group LLC - BioCentury Company Profiles for the biopharma industrySee details»

G2MC: Partners and Funders - Global Genomic Medicine โ€ฆ

The Global Alliance for Genomics and Health (GA4GH) The Global Alliance for Genomics and Health (GA4GH) was formed to help accelerate the potential of genomic medicine to advance โ€ฆSee details»

Genomics Market Size & Growth | Global Forecast [2024-2032]

Dec 16, 2024 The global genomics market was valued at USD 27.75 billion in 2023. The market is projected to be worth USD 30.75 billion in 2024 and reach USD 80.17 billion by 2032, โ€ฆSee details»

Increasing the value of genomic data with global consortia | World ...

Jul 30, 2020 The Australian Genomics Health Alliance (Australian Genomics) is an example of a national-scale genomic data consortium that has driven considerable value for partner โ€ฆSee details»

Cofactor Genomics, Inc. Announces CEO Transition in Preparation โ€ฆ

4 hours ago ST. LOUIS, January 08, 2025--Cofactor Genomics, Inc., a commercial-stage company bridging the precision medicine gap by decoding RNA, announced that experienced โ€ฆSee details»

Genomic Data Governance and Compliance Unlocking

Organizations should anonymize data, limit access, and implement encryption. The Genetic Information Nondiscrimination Act (GINA) ... The Global Alliance for Genomics and Health โ€ฆSee details»

Form S-3/A Bionano Genomics, Inc. - streetinsider.com

1 hour ago Bionano Genomics, Inc. (the โ€œCompanyโ€) is filing this Amendment No. 1 to its Registration Statement on Form S-3 (File No. 333-284124) (the โ€œRegistration Statementโ€) filed โ€ฆSee details»

IHCC: Partners and Associated Organizations - Global Genomic โ€ฆ

Community Partners & Associated Organizations Industry Partners Associated Organizations Global Alliance for Genomics & Health (GA4GH) International Common Disease Alliance (ICDA)See details»

Drug Company to Share Revenues With Indigenous People Who โ€ฆ

1 day ago When Stephane Castel first met with a group of Mฤori people and other Pacific Islanders in New Zealand to talk about his drug companyโ€™s plans for genetic research, locals โ€ฆSee details»

Global Genomics Group - Crunchbase Company Profile & Funding

View contacts for Global Genomics Group to access new leads and connect with decision-makers. View All Contacts . Details. Edit Details Section. Industries . Analytics . Big Data . ...See details»

linkstock.net © 2022. All rights reserved